Insider Stock Trading History of Macdonald Guy


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Macdonald Guy since year 2005. The trader's CIK number is 1296998. At the time of this reporting, Macdonald Guy is the President and Chief Executive of Tetraphase Pharmaceuticals Inc . (stock ticker symbol TTPH). See this page for all insider trading activities at Tetraphase Pharmaceuticals Inc .

Note that in the past Macdonald Guy also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Macdonald Guy since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-09 TTPH Tetraphase Pharmaceuticals Inc Option Ex 30,378 2.90 88,096
2016-06-24 SCYX Scynexis Inc Buy 40,000 2.39 95,600
2016-05-16 TTPH Tetraphase Pharmaceuticals Inc Option Ex 25,323 .87 22,031
2016-01-06 TTPH Tetraphase Pharmaceuticals Inc Option Ex 12,000 .87 10,440
2015-09-01 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 41.57 415,700
2015-09-01 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 7.94 79,400
2015-08-24 TTPH Tetraphase Pharmaceuticals Inc Option Ex 12,000 .87 10,440
2015-08-06 TTPH Tetraphase Pharmaceuticals Inc Sale 30,000 43.65 1,309,500
2015-08-03 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 7.94 79,400
2015-08-03 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 47.45 474,500
2015-07-20 TTPH Tetraphase Pharmaceuticals Inc Sale 15,000 50.72 760,800
2015-07-01 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 7.94 79,400
2015-07-01 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 47.92 479,200
2015-06-01 TTPH Tetraphase Pharmaceuticals Inc Sale 16,087 41.92 674,367
2015-06-01 TTPH Tetraphase Pharmaceuticals Inc Option Ex 30,000 4.41 132,150
2015-05-11 TTPH Tetraphase Pharmaceuticals Inc Option Ex 20,000 7.94 158,800
2015-05-11 TTPH Tetraphase Pharmaceuticals Inc Sale 20,000 41.51 830,200
2015-03-26 TTPH Tetraphase Pharmaceuticals Inc Option Ex 20,000 .87 17,400
2015-03-02 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 7.94 79,400
2015-03-02 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 39.28 392,849
2015-02-02 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 35.51 355,100
2015-02-02 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 7.94 79,400
2015-01-20 TTPH Tetraphase Pharmaceuticals Inc Option Ex 34,135 4.16 142,001
2015-01-20 TTPH Tetraphase Pharmaceuticals Inc Sale 34,135 36.59 1,248,965
2014-09-23 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 2.03 20,299
2014-09-23 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 18.47 184,660
2014-09-17 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 18.00 180,000
2014-09-17 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 .87 8,700
2014-08-20 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 .87 8,700
2014-08-20 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 11.59 115,900
2014-08-05 TTPH Tetraphase Pharmaceuticals Inc Option Ex 25,000 .87 21,750
2014-07-18 TTPH Tetraphase Pharmaceuticals Inc Option Ex 40,000 .87 34,800
2014-07-18 TTPH Tetraphase Pharmaceuticals Inc Sale 15,000 10.61 159,105
2014-06-17 TTPH Tetraphase Pharmaceuticals Inc Option Ex 15,000 .87 13,050
2014-06-17 TTPH Tetraphase Pharmaceuticals Inc Sale 15,000 12.28 184,230
2014-05-19 TTPH Tetraphase Pharmaceuticals Inc Sale 15,000 9.00 135,000
2014-05-19 TTPH Tetraphase Pharmaceuticals Inc Option Ex 15,000 .87 13,050
2014-04-14 TTPH Tetraphase Pharmaceuticals Inc Option Ex 15,000 .87 13,050
2014-04-14 TTPH Tetraphase Pharmaceuticals Inc Sale 15,000 9.69 145,350
2014-02-10 TTPH Tetraphase Pharmaceuticals Inc Option Ex 15,000 .87 13,050
2014-02-10 TTPH Tetraphase Pharmaceuticals Inc Sale 15,000 14.42 216,300

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Macdonald Guy (President and Chief Executive of Tetraphase Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.